BI Receives Approval for Circovirus Vaccine

October 25, 2006 — 

Boehringer Ingelheim Vetmedica, Inc.(BIVI) has received USDA approval for Ingelvac® CircoFLEX? to protect swine against diseases caused by porcine circovirus type 2 (PCV2).

The vaccine, which will not be widely available until the first quarter of 2007, is a single dose, 1 ml product with a 21-day withdrawal. It is labeled for use in pigs as young as three weeks of age.

Additional information about the vaccine and the disease is available by calling BIVI at (800) 325-9167.

Source: BIVI Press release, October 24, 2006